Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
Mariana Matias, Jacinta O. Pinho, Maria João Penetra, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3088-3088
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Nanoparticles in Clinical Translation for Cancer Therapy
Deepa Mundekkad, William C. Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1685-1685
Open Access | Times Cited: 177
Melanoma Management: From Epidemiology to Treatment and Latest Advances
Joana Lopes, Cecília M. P. Rodrigues, Maria Manuela Gaspar, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4652-4652
Open Access | Times Cited: 90
Immunogenic cell death in cancer: concept and therapeutic implications
Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 79
Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
Yujie Zhao, Xu Liu, Xinyu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway
Senling Feng, Yongheng Zhou, Hongliang Huang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 38
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?
Ângela Gonçalves, Mariana Matias, Jorge A. R. Salvador, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1600-1600
Open Access | Times Cited: 13
Deep learning and machine intelligence: New computational modeling techniques for discovery of the combination rules and pharmacodynamic characteristics of Traditional Chinese Medicine
Dongna Li, Jing Hu, Lin Zhang, et al.
European Journal of Pharmacology (2022) Vol. 933, pp. 175260-175260
Closed Access | Times Cited: 33
Cu(II) and Zn(II) Complexes of New 8-Hydroxyquinoline Schiff Bases: Investigating Their Structure, Solution Speciation, and Anticancer Potential
Leonor Côrte‐Real, Vivien Pósa, Matilde Martins, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 29, pp. 11466-11486
Open Access | Times Cited: 19
Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors
Siyu Zhou, Jinghan Lu, Shiyang Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 17
How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT
Joana Lopes, Cecília M. P. Rodrigues, Maria Manuela Gaspar, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1817-1817
Open Access | Times Cited: 25
Exploring the application of metal-based photothermal agents in photothermal therapy combined with immune checkpoint therapy
Bin Xie, Zunqiang Xiao, Jiabao Ling, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Emerging Technologies for Timely Point‐of‐Care Diagnostics of Skin Cancer
James Thomas, Adrian Heagerty, Pola Goldberg Oppenheimer
Global Challenges (2025)
Open Access
Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines
Jasoda Choudhari, Ramakrishna Nimma, Snehal K. Nimal, et al.
Journal of Ethnopharmacology (2023) Vol. 312, pp. 116472-116472
Closed Access | Times Cited: 12
A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma
Jacinta O. Pinho, Mariana Matias, Ana Godinho‐Santos, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123011-123011
Open Access | Times Cited: 9
Bambu and its applications in the discovery of active molecules against melanoma
Isadora Leitzke Guidotti, Alessandra Neis, Daniela Peres Martinez, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 124, pp. 108564-108564
Closed Access | Times Cited: 9
Iodinated 4,4’‐Bipyridines with Antiproliferative Activity Against Melanoma Cell Lines
Paola Peluso, Victor Mamane, Ylenia Spissu, et al.
ChemMedChem (2024) Vol. 19, Iss. 12
Closed Access | Times Cited: 3
Phytochemical Analysis, In Vitro Biological Activities, and Computer-Aided Analysis of Potentilla nepalensis Hook Compounds as Potential Melanoma Inhibitors Based on Molecular Docking, MD Simulations, and ADMET
Subhash Sharma, Vikas Kumar, Muhammad Yaseen, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5108-5108
Open Access | Times Cited: 7
Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine
Nasim Vahidfar, Mohsen Bakhshi Kashi, Saeed Afshar, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 2
Pneumatic extrusion bioprinting-based high throughput fabrication of a melanoma 3D cell culture model for anti-cancer drug screening
Maryke de Villiers, Awie F. Kotzé, Du Plessis
Biomedical Materials (2024) Vol. 19, Iss. 5, pp. 055034-055034
Closed Access | Times Cited: 2
Feasibility of Concentric Electrodes in Contact Irreversible Electroporation for Superficial Lesion Treatment
K. Kurata, Hirotaka Naito, Hiroshi Takamatsu
IEEE Transactions on Biomedical Engineering (2022) Vol. 69, Iss. 8, pp. 2480-2487
Closed Access | Times Cited: 5
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
Ernesto Rossi, Giovanni Schinzari, Francesco Cellini, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 2
A novel inflammatory response-related signature predicts the prognosis of cutaneous melanoma and the effect of antitumor drugs
Jiahua Xing, Yan Li, Youbai Chen, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Thymoquinone oxime synthesis and its effects on melanoma cells: cytotoxic, genotoxic, and apoptotic evaluation
Kübra Bozalı, Sümeyye Koç, Hakan Beyaztaş, et al.
Natural Product Research (2024), pp. 1-9
Open Access
Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors
Dhanashri D Chavan, Rohit R. Bhosale, Vandana M Thorat, et al.
Cureus (2024)
Open Access
Liposomal Formulation of an Organogold Complex Enhancing Its Activity as Antimelanoma Agent—In Vitro and In Vivo Studies
Jacinta O. Pinho, Mariana Coelho, Catarina Pimpão, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1566-1566
Open Access
Page 1 - Next Page

Scroll to top